Founded in 1990 and led by physicians, APLUSA is one of the world’s leading independent global healthcare market research firms. The company specializes in studies leveraging proprietary or custom-developed Real-World Databases (RWD) to serve the healthcare industry.

Building on its track record of success, the dedication of its teams, and a culture of excellence, APLUSA is entering an exciting new phase of growth. The company is committed to delivering even greater value to its clients through innovative solutions and by further expanding its Real-World Evidence (RWE) capabilities.

To drive this ambition forward, Gema Parlange Iturmendi will join APLUSA in December 2024 as CEO. With 30 years of experience in life sciences—including senior roles in finance, commercial leadership, and general management at IQVIA and PAREXEL, as well as co-founding Lumanity, where she served as Chief Commercial Officer and Global Leader RWE—Gema brings unparalleled expertise and a dynamic vision to APLUSA.

She will work alongside Dr. Christine Maï, Deputy Managing Director, who has been an integral part of APLUSA’s success since its founding. Together with the Executive Committee and the entire international APLUSA team, they are united in their enthusiasm to advance the company’s mission.

As Dr. Pierre Pigeon, Founder and Board Member, highlights:
« I am confident that Gema’s strong leadership and fresh perspective, combined with Christine’s exceptional experience and dedication, will drive us forward in achieving our ambition of becoming a long-term leader in our market. Together, they will accelerate innovation, expand our global reach, and nurture the growth of our teams to deliver even greater value to our clients, to the benefit of the patients and healthcare professionals. »